Ligand Pharmaceuticals
LGND
#3614
Rank
โ‚น327.16 B
Marketcap
โ‚น16,623
Share price
-0.97%
Change (1 day)
65.14%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): โ‚น6.17 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.25 Billion. In 2024 the company made an earning of โ‚น0.50 Billion a decrease over its 2023 earnings that were of โ‚น5.80 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น6.17 B1132.25%
2024 โ‚น0.50 B-91.37%
2023 โ‚น5.80 B-7.59%
2022 โ‚น6.28 B4%
2021 โ‚น6.04 B296.42%
2020 โ‚น1.52 B-97.97%
2019 โ‚น75.18 B275.62%
2018 โ‚น20.01 B237.48%
2017 โ‚น5.93 B49.05%
2016 โ‚น3.97 B55.41%
2015 โ‚น2.56 B36.87%
2014 โ‚น1.87 B29.59%
2013 โ‚น1.44 B1309.35%
2012 โ‚น0.10 B-43.97%
2011 โ‚น0.18 B-113.19%
2010 -โ‚น1.39 Billion59.86%
2009 -โ‚น0.87 Billion-61.33%
2008 -โ‚น2.25 Billion-58.75%
2007 -โ‚น5.44 Billion20.52%
2006 -โ‚น4.52 Billion81.27%
2005 -โ‚น2.49 Billion
2003 -โ‚น1.74 Billion-20.6%
2002 -โ‚น2.19 Billion4.38%
2001 -โ‚น2.09 Billion-48.83%
2000 -โ‚น4.09 Billion-19.74%
1999 -โ‚น5.09 Billion-19.06%
1998 -โ‚น6.29 Billion126.71%
1997 -โ‚น2.78 Billion-5.83%
1996 -โ‚น2.95 Billion136.23%
1995 -โ‚น1.25 Billion-33.97%
1994 -โ‚น1.89 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
โ‚น744.65 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
-โ‚น5.59 Billion-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น842.10 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
โ‚น2.085 T 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.070 T 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.032 T 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น725.59 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚น24.39 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.926 T 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA